# Schistosomiasis Diagnosis Using a CAA Antigen Test

> **NCT03779347** · PHASE3 · UNKNOWN · sponsor: **Centre de Recherche Médicale de Lambaréné** · enrollment: 100 (estimated)

## Conditions studied

- Schistosomiasis Hematobium
- Diagnostic
- Drug Reaction
- Pregnancy

## Interventions

- **DRUG:** Praziquantel
- **DIAGNOSTIC_TEST:** UCP-LF CAA
- **DIAGNOSTIC_TEST:** composite diagnostic

## Key facts

- **NCT ID:** NCT03779347
- **Lead sponsor:** Centre de Recherche Médicale de Lambaréné
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-01
- **Primary completion:** 2022-04-01
- **Final completion:** 2022-05-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2021-07-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03779347

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03779347, "Schistosomiasis Diagnosis Using a CAA Antigen Test". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03779347. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*